期刊文献+

利用医院集中监测药物不良反应管理系统适时监测药物性肝损害 被引量:2

Timely Monitoring of Drug-induced Liver Injury by Using the Hospital Centralized Management System for Monitoring AD
下载PDF
导出
摘要 目的探讨针对药物性肝损害患者采用医院集中监测药物不良反应管理系统加以适时监测后获得的效果。方法选择该院2014年8月—2016年8月表现出ALT(丙氨酸氨基转移酶)水平异常、或者AST(门冬氨酸氨基转移酶)水平异常、或者Tbil(总胆红素)水平异常的患者102例作为该次实验观察对象;针对患者用药过程中表现出药物性肝损害,有效利用医院集中监测药物不良反应管理系统加以适时监测,最终对监测结果进行分析。结果分析表现出药物不良反应的患者共包括15例,涉及到的药物种类共包括5类,共包括20种;临床属于不合理用药的患者共包括5例,涉及到的药物种类共包括7种。结论采用医院集中监测药物不良反应管理系统对患者用药情况加以适时监测,针对药物性肝损害信息可以进行有效明确,针对医院药物不良反应监测的集中开展提供有力依据。 Objective To study the effect of timely monitoring of patients with drug-induced liver injury by using the?hospital centralized management system for monitoring AD.Methods 102 cases of patients with abnormal ALT level,AST level and Tbil level in our hospital from August 2014 to August 2016 were selected as the observation objects,the drug-induced liver injury of patients in the medication course was given the timely monitoring by effective use of the hospital centralized management system for monitoring AD,and the monitoring results were analyzed finally.Results 15 cases were with drug adverse reactions,involving 5 categories,and there were 20 kinds in the 5 categories;5 cases were with clinical irrational medication in clinic,involving 7 categories of drugs.Conclusion The timely monitoring of medication of patients by using the hospital centralized management system for monitoring AD can effectively definite the drug-induced liver injury information and provide powerful basis for the concentrated development of hospital drug adverse reaction monitoring.
作者 谢莹霞 刘源
出处 《中国卫生产业》 2016年第29期12-14,共3页 China Health Industry
关键词 医院集中监测药物不良反应管理系统 药物性肝损害 监测效果 Hospital centralized management system for monitoring AD Drug-induced liver injury Monitoring effect
  • 相关文献

参考文献5

二级参考文献41

  • 1付国印.对153例药物性肝损害事件的临床分析[J].求医问药(下半月),2013(10):145-146. 被引量:1
  • 2林京玉(编译),丁日高(校).抗菌药和药物性肝损伤[J].国外医学(药学分册),2006,33(3):195-197. 被引量:12
  • 3陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011:32-33.
  • 4林静,王亚丽,王海燕.老年人急性药物性肝病临床分析30例[J].世界华人消化杂志,2007,15(18):2059-2062. 被引量:13
  • 5Maria V A, Victorino R M. Development and validation of a clinical scale for the diagnosis of drug- induced hepatitis[J]. Hepatology, 1997, 26(3): 664.
  • 6Daly A K, Day C P. Genetic association studies in drug - in- duced liver injury[J]. Semin Liver Dis, 2009, 29(4): 400.
  • 7FDA. Guidance for Industry Drug-Induced Liver Injury: Pre- marketing Clinical Evaluation [ EB/OL ]. http://www, fda. gov/ downloads/ drugs/ guidancecomplianceregulatory- information/guida -nces/twm174090. pdf ,2009-07/2013-08.
  • 8Benichou C. Criteria of dmg-in, iuced liver disorders. Report of an international consensus meeting [ J ~. J ttepatol, 1990, 11 (2) :272-276.
  • 9Schiodt FV, Atillasoy E,Shakil O,et al. Etiology and outcome for 295 patients with acute liver failure in the United Sates [J]. Liver Transpl Surg,1999,5( 1 ) :29-34.
  • 10Meier Y, Cavallaro M, Roos M, et al. Incidence of drug in- duced liver injury in medical inpatients[ J ]. Eur J Clin Phar-maco1,2005,61 (2) :135-143.

共引文献41

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部